Literature DB >> 2119867

[Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].

M Fardeau1, F M Tomé, H Collin, N Augier, F Pons, J Léger, J Léger.   

Abstract

We have studied by indirect immunofluorescence, using three different polyclonal antidystrophin antibodies raised against fusion proteins, the neuromuscular junctions (NMJs) in muscle biopsies from Duchenne muscular dystrophy (DMD) patients, from human controls and mutant "mdx" mice and normal mice. In controls the periphery of all muscle fibres was strongly labelled by the three dystrophin antibodies and there was a high concentration of labelling at the NMJs (where it was co-localized with acetylcholine receptor labelled by the alpha-bungarotoxin). In DMD and in "mdx" mice the NMJs were equally labelled whereas there was an absence of reaction at the periphery of all (DMD) or most ("mdx" mice) muscle fibers. These findings suggest that a dystrophin-like protein, which was identified by the antibodies we have used, is present at the NMJs in the Duchenne's myopathy and "mdx" mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119867

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  10 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

Authors:  D Récan; P Chafey; F Leturcq; J P Hugnot; N Vincent; F Tomé; H Collin; D Simon; P Czernichow; L V Nicholson
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 3.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

4.  Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein.

Authors:  A O Gramolini; L M Angus; L Schaeffer; E A Burton; J M Tinsley; K E Davies; J P Changeux; B J Jasmin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 5.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

6.  Dystrophin is a component of the subsynaptic membrane.

Authors:  J E Yeadon; H Lin; S M Dyer; S J Burden
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

7.  Localization of dystrophin gene transcripts during mouse embryogenesis.

Authors:  D Houzelstein; G E Lyons; J Chamberlain; M E Buckingham
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

8.  Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle.

Authors:  R Sealock; M H Butler; N R Kramarcy; K X Gao; A A Murnane; K Douville; S C Froehner
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

9.  The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle.

Authors:  T J Byers; L M Kunkel; S C Watkins
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

10.  The subcellular distribution of chromosome 6-encoded dystrophin-related protein in the brain.

Authors:  T S Khurana; S C Watkins; L M Kunkel
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.